Desai, A.; Xiao, A.H.; Choi, D.; Toruner, M.D.; Walden, D.; Halfdanarson, T.R.; Alberts, S.; McWilliams, R.R.; Mahipal, A.; Ahn, D.;
et al. Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Cancers 2024, 16, 1861.
https://doi.org/10.3390/cancers16101861
AMA Style
Desai A, Xiao AH, Choi D, Toruner MD, Walden D, Halfdanarson TR, Alberts S, McWilliams RR, Mahipal A, Ahn D,
et al. Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Cancers. 2024; 16(10):1861.
https://doi.org/10.3390/cancers16101861
Chicago/Turabian Style
Desai, Aakash, Alexander H. Xiao, Daheui Choi, Merih D. Toruner, Daniel Walden, Thorvardur R. Halfdanarson, Steven Alberts, Robert R. McWilliams, Amit Mahipal, Daniel Ahn,
and et al. 2024. "Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma" Cancers 16, no. 10: 1861.
https://doi.org/10.3390/cancers16101861
APA Style
Desai, A., Xiao, A. H., Choi, D., Toruner, M. D., Walden, D., Halfdanarson, T. R., Alberts, S., McWilliams, R. R., Mahipal, A., Ahn, D., Babiker, H., Stybayeva, G., Revzin, A., Kizilbash, S., Adjei, A., Bekaii-Saab, T., Mansfield, A. S., Carr, R. M., & Ma, W. W.
(2024). Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Cancers, 16(10), 1861.
https://doi.org/10.3390/cancers16101861
